Recombinant Rat CX3CL1/Fractalkine (Chemokine Domain)
R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Source: | E. coli |
Accession #: | O55145 |
Applications: | Bioactivity |
Customers also Viewed
Citations for Recombinant Rat CX3CL1/Fractalkine (Chemokine Domain) (5)
Citations are publications that use Bio-Techne products. Selected citations for Recombinant Rat CX3CL1/Fractalkine (Chemokine Domain) include:
-
Species: Rat
Sample Types: In Vivo
Applications: BioassayM Jiang et al. (2022), Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy Journal of Cellular and Molecular Medicine, 0(0).
PMID: 35023309 -
Species: Rat
Sample Types: Whole Cells
Applications: BioassayClark A et al. (2015), Selective activation of microglia facilitates synaptic strength. J Neurosci, 35(11):4552-70.
PMID: 25788673 -
Species: Rat
Sample Types: Whole Cells
Applications: BioassayHusberg C et al. (2008), Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J. Mol. Cell. Cardiol., 45(2):261-9.
PMID: 18585734 -
Species: Rat
Sample Types: In Vivo
Applications: In VivoChen X et al. (2007), The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats. Brain Res., 1153(0):52-7.
PMID: 17459345 -
Species: Rat
Sample Types: In Vivo
Applications: In VivoZhuang ZY et al. (2006), Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav. Immun., 21(5):642-51.
PMID: 17174525
There are no citations that match your criteria.